Frequency Therapeutics, Inc.·4

Feb 14, 4:22 PM ET

Hilt Dana Charles 4

4 · Frequency Therapeutics, Inc. · Filed Feb 14, 2020

Insider Transaction Report

Form 4
Period: 2020-02-12
Hilt Dana Charles
Chief Medical Officer
Transactions
  • Award

    Stock Option

    2020-02-12+50,00050,000 total
    Exercise: $25.05Exp: 2030-02-11Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable in equal monthly installments over a four year period commencing on February 1, 2020, and will be fully vested and exercisable on January 1, 2024.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT